Blog
Insights and Strategies To guide your LMI journey
Why Does Studying Adverse Effects Improve Psychedelic Treatment?
Roman Palitsky, PhD, is the Director of Research Projects for Emory Spiritual Health and a Research Psychologist for Emory University School of Medicine. His research examines how culture, spirituality, and health interact, focusing on the biological, psychological, and social pathways that shape health outcomes. Dr. Palitsky is also an Assistant...
Read MoreAttunement, Ethics, and the Inner Directed Approach in Psychedelic Therapy
Eric Sienknecht, PsyD, is the Co-founder and Psychologist at Polaris Insight Center, a ketamine-assisted psychotherapy clinic and training center. As a licensed clinical psychologist, he has experience treating trauma, mood disorders, and chronic pain by integrating psychedelic experiences into therapeutic care. Eric has received advanced training in KAP through the...
Read MoreHow Effective KAP Shifts Patterns and Supports Lasting Change
Peter Corbett, LICSW, is the Founder and Executive Director of Kapstone Clinics, a network of mental health clinics focused on integrative and ketamine-assisted psychotherapy services. He is a seasoned clinical social worker and psychotherapist with more than 30 years of experience across private practice, hospitals, and community mental health settings....
Read MoreInterviews With the Elders: Marcela on Working With Psychedelics and the Importance of Attunement
Marcela Ot’alora is a Psychotherapist, Artist, and Researcher at Memoru, a nonprofit organization focused on psychedelic education, clinical care, training, and research. For over 25 years, she has treated trauma and PTSD using MDMA-assisted therapy. Previously, Marcela was a Principal Investigator and Trainer at MAPS, where she conducted Phase II...
Read MoreHonoring Ancient Wisdom and Guarding Against Harm: What Practitioners Should Know
Dana Lerman, MD, is the Founder of Skylight Psychedelics, a company that trains therapists in psychedelic‑assisted therapy and provides medically supervised ketamine and psychedelic interventions. As a physician trained in internal medicine and infectious diseases, she was the Co-founder of The COVID Consultants, a national COVID-19 consulting and testing firm....
Read MorePsychedelic Oncology – Can Psychedelics Offer Support for Cancer Patients?
Jason Konner, MD, is the Co‑founder of Psychedelic Oncology, an initiative exploring the intersection of psychedelic‑assisted healing and cancer care. As a medical oncologist, he spent over two decades treating patients at Memorial Sloan Kettering Cancer Center. Dr. Konner integrates relational and existential support into oncology to expand clinicians’ understanding...
Read More